The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trial.
Pujol
J L
JL
Hôpital de l'Aiguelongue, Montpellier, France.
Tabah
I
I
Michel
F B
FB
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*
D000970:Antineoplastic Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor